Relmada Therapeutics (RLMD) has had the highest return between March 6, 2025 and March 6, 2026 by a small-cap US stock, returning 1,593.4%.
| ASSET | DATE | % RETURN |
|---|---|---|
Relmada Therapeutics (RLMD) | 3/6/2025 - 3/6/2026 | 1,593.43% |
Battalion Oil (BATL) | 3/6/2025 - 3/6/2026 | 1,166.67% |
Babcock & Wilcox Enterprises (BW) | 3/6/2025 - 3/6/2026 | 1,165.71% |
Nanobiotix (NBTX) | 3/6/2025 - 3/6/2026 | 882.4% |
Ventyx Biosciences (VTYX) | 3/6/2025 - 3/6/2026 | 839.6% |
Santacruz Silver Mining Ltd Common Shares (SCZM) | 3/6/2025 - 3/6/2026 | 759.48% |
Tango Therapeutics (TNGX) | 3/6/2025 - 3/6/2026 | 725% |
CytomX Therapeutics (CTMX) | 3/6/2025 - 3/6/2026 | 666.88% |
Amprius Technologies (AMPX) | 3/6/2025 - 3/6/2026 | 619.32% |
IsoEnergy (ISOU) | 3/6/2025 - 3/6/2026 | 610.46% |
Zepp Health (ZEPP) | 3/6/2025 - 3/6/2026 | 577.62% |
Kodiak Sciences (KOD) | 3/6/2025 - 3/6/2026 | 570.93% |
RAPT Therapeutics (RAPT) | 3/6/2025 - 3/6/2026 | 565.19% |
Almonty Industries Inc Common Shares (ALM) | 3/6/2025 - 3/6/2026 | 549.83% |
United States Antimony (UAMY) | 3/6/2025 - 3/6/2026 | 543.06% |
Charming Medical Limited Class A Ordinary Shares (MCTA) | 3/6/2025 - 3/6/2026 | 539.54% |
Alto Neuroscience (ANRO) | 3/6/2025 - 3/6/2026 | 516.17% |
Avino Silver & Gold Mines (ASM) | 3/6/2025 - 3/6/2026 | 514.62% |
Palvella Therapeutics (PVLA) | 3/6/2025 - 3/6/2026 | 513.41% |
Newegg Commerce (NEGG) | 3/6/2025 - 3/6/2026 | 479.47% |
International Tower Hill Mines (THM) | 3/6/2025 - 3/6/2026 | 478.85% |
Tanzanian Royalty Exploration (TRX) | 3/6/2025 - 3/6/2026 | 466.67% |
Zura Bio Limited - Class A Ordinary shares (ZURA) | 3/6/2025 - 3/6/2026 | 454.1% |
Olema Pharmaceuticals (OLMA) | 3/6/2025 - 3/6/2026 | 446.25% |
Armata Pharmaceuticals (ARMP) | 3/6/2025 - 3/6/2026 | 442.57% |
Small-cap stocks are treated as having a market cap between $300M and $2B.
